EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case–control study

Mosoka P Fallah, Collin Van Ryn, J Soka Moses, Moses Badio, Tamba Fayiah, Kumblytee Johnson, Dehkontee Gayedyu-Dennis, Allen O Eghrari, Sheri D Weiser, Travis C Porco, Jeffrey N Martin, Michael J Peluso und 7 weitere

The Lancet Microbe · 2025

DOI: 10.1016/j.lanmic.2024.101033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Lancet Microbe, 2025. Verfasst von Mosoka P Fallah und 18 weiteren Autor:innen. Beteiligte Einrichtung: Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia; Africa Centres for Disease Control and Preventi…. Hauptthemen laut MEDLINE: Semen, Hemorrhagic Fever, Ebola, Virus Shedding, RNA, Viral. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, FIC NIH HHS, CCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: A high proportion of survivors of Ebola virus disease (EVD) have post-acute sequelae of EVD (PASE), but the relationship between inflammation and PASE pathogenesis is poorly understood. This study tests the hypothesis that inflammation is associated with PASE among survivors with and without viral RNA shedding in the semen. METHODS: This was a case-control study nested in a longitudinal cohort that recruited confirmed survivors of EVD and their uninfected contacts from the 2013-16 EVD epidemic in Liberia, starting on June 1, 2015. We included participants aged at least 18 years with clinical data and plasma available at cohort baseline for analysis. A semen donation substudy tested male survivors for Ebola virus RNA shedding in the semen. A sex-stratified and survivor-stratified random sample of cases (survivors) and controls (contacts) was obtained to select stored baseline plasma samples for cytokine testing of markers of inflammation, immune regulation, and antiviral responses. Serostatus of cases and controls was confirmed by Filovirus Animal Nonclinical Group assay. We identified inflammatory markers (adjusted p≤0·05) elevated in cases compared with controls and then used these biomarkers in analyses comparing survivors with and without pre-specified PASE-associated clinical findings (self-reported symptoms and abnormal examination findings). Survivors with viral RNA shedding in the semen formed subgroup analyses. FINDINGS: Our analysis cohort consisted of 1044 participants (594 survivors of EVD and 450 uninfected contacts); 515 (49·3%) were female and 529 (50·7%) were male. The subcohort of 243 male survivors with data on viral shedding included 81 (33%) participants with viral shedding in semen. Median time from acute EVD to baseline was 317 days (IQR 271-366). Survivors of EVD showed a pattern of elevated inflammatory markers indicative of macrophage (MCP-1, IL-1β, and M-CSF) and angiogenic factor activation (VEGF-A) compared with controls (adjusted p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SemenHemorrhagic Fever, EbolaVirus SheddingRNA, ViralEbolavirusBiomarkersInflammationHumansLiberiaMaleCase-Control StudiesAdultSurvivorsLongitudinal StudiesMiddle AgedCytokinesFemaleYoung Adult

Substanzen

RNA, ViralBiomarkersCytokines

Autor:innen und Institutionen

  • Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia; Africa Centres for Disease Control and Prevention (Africa CDC), Addis Ababa, Ethiopia.
  • Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, MN, USA.
  • Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.
  • Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia; Department of Epidemiology and Biostatistics, University of California, San Francisco (UCSF), San Francisco, CA, USA.
  • The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Department of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA.

Förderung

  • NIAID NIH HHS
  • FIC NIH HHS
  • CCR NIH HHS
  • NCI NIH HHS
  • U.S. Department of Health and Human Services
  • National Cancer Institute
  • Centers for Disease Control and Prevention
  • National Institutes of Health

Zitieren

APA

Fallah, M. P., Van Ryn, C., Moses, J. S., Badio, M., Fayiah, T., Johnson, K., Gayedyu-Dennis, D., Eghrari, A. O., Weiser, S. D., Porco, T. C., Martin, J. N., Peluso, M. J., McIlwain, D. R., Dighero-Kemp, B., Higgs, E., Hensley, L. E., Rutherford, G. W., Reilly, C., & Kelly, J. D. (2025). Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case–control study. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2024.101033

Vancouver

Fallah MP, Van Ryn C, Moses JS, Badio M, Fayiah T, Johnson K, et al. Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case–control study. The Lancet Microbe. 2025. doi:10.1016/j.lanmic.2024.101033

BibTeX
@article{Fallah2025,
  author = {Fallah, Mosoka P and Van Ryn, Collin and Moses, J Soka and Badio, Moses and Fayiah, Tamba and Johnson, Kumblytee and Gayedyu-Dennis, Dehkontee and Eghrari, Allen O and Weiser, Sheri D and Porco, Travis C and Martin, Jeffrey N and Peluso, Michael J and McIlwain, David R and Dighero-Kemp, Bonnie and Higgs, Elizabeth and Hensley, Lisa E and Rutherford, George W and Reilly, Cavan and Kelly, J Daniel},
  title = {Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case–control study},
  journal = {The Lancet Microbe},
  year = {2025},
  doi = {10.1016/j.lanmic.2024.101033}
}
Kostenlos starten →